Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Gerhard-Rüdiger Burmester

77PUBLICATIONS
307CO-AUTHORS
Molecular targetsAutoimmunityRheumatology and arthritisMedical biotechnology diagnostics (incl. biosensors)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (77)

Sort by Publication Date:
|Jan 12, 2026
Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA).

Georg Pongratz, Rieke Alten, Torsten Witte

|Sep 01, 2025
To optimise the diagnostic process of rheumatic diseases affecting the hands using fluorescence optical imaging (FOI).

Nele Stumper, Jörn Berger, Jens Klotsche

|Aug 28, 2025
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease.

Gerd R Burmester, Atul Deodhar, Alan D Irvine

|Aug 28, 2025
Medical Expert Knowledge Meets AI to Enhance Symptom Checker Performance for Rare Disease Identification in Fabry Disease: Mixed Methods Study.

Anne Pankow, Nico Meißner-Bendzko, Jessica Kaufeld

|Jun 03, 2025
Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease.

|Jan 13, 2025
Usability, efficacy, and safety of candidate tocilizumab biosimilar CT-P47 self-administration via auto-injector and pre-filled syringe in patients with rheumatoid arthritis: a single-arm, open-label, phase 3 study.

Gerd Burmester, Piotr Adrian Klimiuk, Jakub Trefler

Pageof 13

Frequent Collaborators

9 joint publications

Kevin Winthrop

7 joint publications

Désirée van der Heijde

7 joint publications

Tanja A Stamm

7 joint publications

Daniel Aletaha

7 joint publications

Robert Biesen

7 joint publications

Yoshiya Tanaka

6 joint publications

Tsutomu Takeuchi

6 joint publications

Laure Gossec

6 joint publications

Johannes Wj Bijlsma

6 joint publications

Hendrik Schulze-Koops

Frequent Collaborators

9 joint publications

Kevin Winthrop

7 joint publications

Désirée van der Heijde

7 joint publications

Tanja A Stamm

7 joint publications

Daniel Aletaha

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.5K
Non-invasive <em>In Vivo</em> Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
06:46

Non-invasive <em>In Vivo</em> Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent

Published on : May 08, 2017

8.9K
See more related videos

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.5K
Non-invasive <em>In Vivo</em> Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
06:46

Non-invasive <em>In Vivo</em> Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent

Published on : May 08, 2017

8.9K
See more related videos